Zach Wohlberg

About the Author Zach Wohlberg

Zach is currently studying Finance at the University of Maryland and is originally from Stamford, CT. He is most interested in public markets and Macroeconomic trends.

Sectoral’s Jerome Pfund Is Losing Faith in PTC Therapeutics, Inc. (PTCT), Starting to Pull Away from Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and DexCom, Inc. (DXCM)

Here’s a glimpse into this hedge fund guru’s Q2 moves that reeled back in three biotech players.

Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

Morgan Stanley Provides a Glimpse into its Global Healthcare Conference: Gilead Sciences, Inc. (GILD), Biogen Inc (BIIB), Celgene Corporation (CELG)

Last week, representatives from some of the largest healthcare companies in the world flocked to New York City to participate in Morgan Stanley’s …

Alphabet Inc (GOOGL): Partnerships with Sanofi and Chipotle Headline A Busy Week

Google parent Alphabet Inc (NASDAQ:GOOGL) was founded in 2015 to allow for more transparency regarding the company’s subsidiaries that are unrelated to its core …

Mylan NV (MYL) Facing Public Image and Legal Problems After EpiPen Scandal

Over the last several years there have been several instances of pharmaceutical companies increasing the price of its drugs by unfathomable proportions. The …

State Judge‘s Ruling Puts Tesla Motors Inc (TSLA) Missouri Business in Jeopardy

The experience Tesla Motors Inc (NASDAQ:TSLA) created for a customer when it enters a showroom is perfectly designed to entice them into purchasing …

Busy Week for Apple Inc. (AAPL) Between Tax Dispute and Rumored iPhone 7 Release

Apple Inc. (NASDAQ:AAPL) established itself as a household name once it released the iPod in the early 2000s and quickly took over multiple markets, making …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts